Jennifer Cote
Chief Financial Officer, Harvard Bioscience.
Companies
- Harvard BioscienceChief financial officer Jan 3, 2023 to May 14, 20251
- Harvard BioscienceBoard member Jan 3, 2024 to Jan 3, 20242
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Harvard Bioscience HBIO159,019 shares3$1.3M at $8.05Mar 19, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Mar 19, 2025Shares withheld for tax 5,687 shares at $0.69 of Harvard Bioscience3
- Dec 29, 2024Shares withheld for tax 3,797 shares at $1.98 of Harvard Bioscience4
- Dec 29, 2024Shares withheld for tax 4,731 shares at $1.98 of Harvard Bioscience4
- Mar 6, 2024Shares withheld for tax 9,920 shares at $4.11 of Harvard Bioscience5
- Mar 5, 2024Granted 35,800 shares of Harvard Bioscience5
- Mar 5, 2024Granted 35,800 shares of Harvard Bioscience5
- Dec 29, 2023Shares withheld for tax 2,631 shares at $5.35 of Harvard Bioscience6
- Dec 29, 2023Shares withheld for tax 3,279 shares at $5.35 of Harvard Bioscience6
- Mar 6, 2023Granted 29,880 shares of Harvard Bioscience7
- Mar 6, 2023Granted 25,862 shares of Harvard Bioscience7
- Mar 6, 2023Granted 26,892 shares of Harvard Bioscience7
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARHarvard Bioscience, Board member
- 3
- 4SEC EDGARForm 4 filed Dec 31, 2024
- 5SEC EDGARForm 4 filed Mar 7, 2024
- 6SEC EDGARForm 4 filed Jan 3, 2024
- 7SEC EDGARForm 4 filed Mar 8, 2023